Meds Apotek AGM approved the income statement and balance sheet
No dividend is proposed for 2025. The board was re-elected and authorization for a new share issue was granted.
See the latest news and media coverage for MEDS. We track all announcements, press releases, and industry mentions in real time, all in one place.
Online pharmacy for medicines and health products
meds.seLast updated
In short: MEDS Apotek achieved a net sales milestone of SEK 1 billion in 2025 and continued its growth into Q1 2026 while expanding logistics capabilities.
No dividend is proposed for 2025. The board was re-elected and authorization for a new share issue was granted.
Net sales rose 12% to SEK 270 million. EBIT was SEK 5.2 million with 1.9% margin. CEO highlights market share gains and logistics investments.
The report publishes May 5 at 07:30 CEST, with webcast at 09:30 CEST by CEO Björn Thorngren and CFO Nick Mendola. Email ir for link.
The report is available on the company's website. English translation will be available before the annual general meeting on 21 May 2026.
January - March 2026Net sales increased by 12% (29%) to SEK 270 million (242).Operating profit (EBIT) was SEK 5.2 million (5.5), corresponding to an EBIT...
By signing up for the free subscription Affärsvärlden Free, you get a selection of all our material, as well as a daily newsletter with the latest news.
Two pharmacies in Stockholm in the suspected fraud case are closed with immediate effect, reports SVT Stockholm. According to ...
Earnings call MEDS Apotek reported 15% YoY net sales growth in Q4, outperforming the estimated 14% market growth. FY EBIT margin turned positive at 1.5...
Track MEDS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to MEDS and other trending companies.